These findings are clinically relevant given the roles of NF‐L and T‐tau as prognostic biomarkers of global and domain‐specific cognitive decline and neuroimaging markers of cortical thickness, hippocampal volume, white matter integrity and white matter hyperintensity volume in patients without dementia (Marks et al., 2021). The gene discussed is MAPT; the disease is dementia.